Does Calcium Antagonists Interact with Beta Carotene Vitamin A Acetate Ascorbic Acid Cholecalcifero?
CDI records a major classification for Calcium Antagonists and Beta Carotene Vitamin A Acetate Ascorbic Acid Cholecalcifero. The stored summary is: Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. The mechanism involves risk of hypercalcemia and kidney stone formation. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Risk of hypercalcemia and kidney stone formation
What To Tell Your Doctor or Pharmacist
If you are taking Calcium Antagonists and your doctor is considering prescribing Beta Carotene Vitamin A Acetate Ascorbic Acid Cholecalcifero (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider